Search results

Found 49 pages
AUTHOR: Claire Bowie

Results per page

10 20 50 100

Sort by

Relevance Date

7 Oct 2010:

ICON wins accreditation for UK unit

ICON’s clinical pharmacology unit, based in Manchester, has achieved the highest level of accreditation in Europe from the Medicines and Healthcare products Regulatory Agency. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/icon_wins_accreditation_for_uk_unit_982294

19 Jun 2009:

Pfizer's Viagra patent upheld in Canada

Pfizer’s Viagra (sildenafil) will be protected from generic competition in Canada until its patent expires in 2014, the country’s Federal Court ruled yesterday. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/pfizers_viagra_patent_upheld_in_canada_984648

30 Jun 2009:

Sanofi-Aventis looks to more generic buys

The head of Sanofi-Aventis, Chris Viehbacher, has played down suggestions that a major merger is on the cards and instead plans to increase its geographical spread by snapping up more generic drug firms. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/sanofi-aventis_looks_to_more_generic_buys_984579

8 Oct 2009:

FDA spotlights drug safety issues

The FDA's latest quarterly report from its Adverse Event Reporting System has spotlighted a number of drugs with a potential safety issue or that have had new safety information attributed to them between January and March of this year. - News -

by Claire Bowie

https://www.pharmatimes.com/news/fda_spotlights_drug_safety_issues_984488

7 Mar 2014:

Where next for the human genome?

The dotcom pioneer Joe Kraus recently said that "the 20th century was about dozens of markets of millions of consumers. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/where_next_for_the_human_genome_1001636

19 Jun 2009:

Sanofi loses Eloxatin battle – for now

Sanofi-Aventis has lost its court battle to prevent generic drugmakers from launching their own versions of its blockbuster cancer drug Eloxatin (oxaliplatin), but says it intends to appeal. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/sanofi_loses_eloxatin_battle_for_now_984647

7 Oct 2010:

EU patients to get voice in drug safety

Patients and consumers across Europe will soon be able to directly report any adverse reactions to medicines, following approval by the European Parliament for it to be made a legal provision. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/eu_patients_to_get_voice_in_drug_safety_982292

13 Aug 2009:

New Prevnar sees delay in USA

The much anticipated approval of Wyeth's new version of its blockbuster childhood vaccine Prevnar has been delayed by three months after the US Food and Drug Administration sought more time to review the data. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/new_prevnar_sees_delay_in_usa_983827

30 Jun 2009:

J&J wins $1.67 billion in Abbott patent case

Centocor Ortho Biotech, a unit of Johnson & Johnson, has been awarded a whopping $1.67 billion in a patent infringement suit against Abbott Laboratories. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/j_and_j_wins_$1.67_billion_in_abbott_patent_case_984576

5 Jan 2011:

Dr Reddy's to challenge Lipitor suit

India’s Dr Reddy’s Laboratories has told the country’s leading newspaper it will challenge a US patent infringement suit filed against it by the world’s number one pharmaceutical giant, Pfizer, last month. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/dr_reddys_to_challenge_lipitor_suit_979829